Professional Documents
Culture Documents
Nervous System
(Classifications)
N203
ATI (Unit 5)
Nervous System -
Atropine
Ganglionic-stimulating agents
Cholinesterase inhibitors (ChE)
Neuromuscular-blocking agents
Nicotine
Physostigmine or neostigmine
Tubocurarine
Bethanechol
Epinephrine
NicotinicN Receptors
N203
ATI (Unit 5)
Nervous System -
NicotinicM Receptors
N203
ATI (Unit 5)
Nervous System -
Muscarinic Receptors
N203
ATI (Unit 5)
Nervous System -
Alpha1 Receptors
N203
ATI (Unit 5)
Nervous System -
Dopamine Receptors
N203
ATI (Unit 5)
Nervous System -
Beta1 Receptors
N203
ATI (Unit 5)
Nervous System -
Beta2 Receptors
N203
ATI (Unit 5)
Nervous System -
Dilates bronchi
Relaxes uterine smooth muscle
Vasodilation of arterioles in heart, lungs, and skeletal muscle
Slightly peripheral resistance
glycogenolysis in the liver and muscles
Skeletal muscle contraction
Parkinsons Disease
N203
ATI (Unit 5)
Nervous System -
Seizure Disorders
N203
ATI (Unit 5)
Nervous System -
Schizophrenia
N203
ATI (Unit 5)
Nervous System -
exacerbations
Positive symptoms (Agitation, delusions)
Atypical antipsychotic
Clozapine
at bedtime.
Depression
N203
ATI (Unit 5)
Nervous System -
Symptom relief can take 1-3 weeks and possibly 2-3 months
Three main groups:
Tricyclic antidepressants (TCAs)
Selective serotonin reuptake inhibitors (SSRIs)
Monamine oxidase inhibitors (MAOIs)
Bipolar Disorder
N203
ATI (Unit 5)
Nervous System -
Cholinesterase Inhibitors
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Therapeutic Uses:
Neuromuscular Blocking
Agents
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Depolarizing: succinylcholine
Contraindications/Precautions:
SCh: CI for hyperkalemia (trauma, burns)
General anesthetics
Interactions:
Aminoglycosides/tetracyclines - NM blockade
Dopaminergics
(Anti-Parkinsons)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
COMT
N203
ATI (Unit 5)
Nervous System -
Catechol O-Methyltransferase
Deactivates catecholamines (dopamine, norepinephrine, acetylcholine,
degrades norepinephrine.
Also found in gut
Dopamine Agonists
(Anti-Parkinsons)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Interactions:
Centrally Acting
Anticholinergics
(Anti-Parkinsons)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Block ACh at muscarinic receptors which helps maintain ACh, dopamine balance
Nausea (take food)
Adverse Effects:
Contraindications/Precautions:
CI in narrow-angle glaucoma
Interactions:
Education:
Antiviral
(Anti-Parkinsons)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Proto: Amantadine
Interactions:
Education:
Antiepileptic Medications
(Medication List)
N203
ATI (Unit 5)
Nervous System -
Barbiturates
phenobarbital (Luminal)
Hydantoins
phenytoin (Dilantin)
...............................................................................................
Lorazepam (Ativan)
...............................................................................................
Carbamazepine (Tegretol)
...............................................................................................
Ethosuximide (Zarontin)
...............................................................................................
Valproic acid (Depakote)
...............................................................................................
Gabapentin (Neurontin)
Other meds
lamotrigine (Lamictal)
...............................................................................................
oxcarbazepine (Trileptal)
Barbiturate
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Therapeutic Uses:
CNS effects: Adults as sedation and anxiety, kids as irritability and hyperactivity
Toxicity: Nystagmus, ataxia, respiratory depression, pinpoint pupils
Pregnancy (D)
Contraindications/Precautions:
CI intermittent porphyria
Interactions:
Education:
Hydantoins
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Therapeutic Uses:
CNS effects
Skin rash
Teratogenic
Cardiovascular
Endocrine effects
Gingival hyperplasia
Vitamin D metabolism
Contraindications/Precautions:
Carbamazepine
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Therapeutic Uses:
Proto: Tegretol
Adverse Effects:
Contraindications/Precautions:
Interactions:
Education:
Ethosuximide
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Therapeutic Uses:
Interactions:
Education:
Proto: Zarontin
Valproic Acid
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Proto: Depakote
Therapeutic Uses:
Liver disorders
Interactions:
Gabapentin
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Proto: Neurontin
Therapeutic Uses:
Interactions:
Education:
Neuropathic pain
Migraine prev.
Benzodiazepines
(Antiepileptic)
N203
ATI (Unit 5)
Nervous System -
Therapeutic Uses:
Respiratory depression
Anterograde amnesia
Teratogenic
Contraindications/Precautions:
Interactions:
Education:
Muscle Relaxants /
Antispasmodics
(Medication List)
N203
ATI (Unit 5)
Nervous System -
Baclofen (Lioresal)
Cyclobenzaprine (Flexeril)
Metaxalone (Skelaxin)
Diazepam
(Muscle Relaxant / Antispasmodic)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Adverse Effects:
CNS depression Physical dependence from long-term use
Contraindications/Precautions:
Pregnancy (D)
Interactions:
Centrally Acting
(Muscle Relaxant / Antispasmodic)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Therapeutic Uses:
Adverse Effects:
Cue
(Muscle Relaxant / Antispasmodic)
N203
ATI (Unit 5)
Nervous System -
Response
Peripherally Acting
(Muscle Relaxant / Antispasmodic)
N203
ATI (Unit 5)
Nervous System -
Name: Dantrolene
Expected Action:
(Dantrium)
CNS depression
Hepatic toxicity
Contraindications/Precautions:
Pregnancy (C)
Interactions:
Local Anesthetics
N203
ATI (Unit 5)
Nervous System -
Expected Action:
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Interactions:
Opioids: constipation & urinary
CNS depressants: Additive effect
retention
Adverse Effects:
Education:
Intravenous Anesthetics
(Key Points)
N203
ATI (Unit 5)
Nervous System -
Ketamine (Ketalar)
Amnesia
Intravenous Anesthetics
(Effects and Interactions)
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Contraindications/Precautions:
Ketamine should be avoided with psychiatric disorders
Interactions:
CNS depressants and stimulants: Additive effects
Opioid analgesics: Constipation and urinary retention
Education:
Midazolam (Versed): inject over >2 minutes
Propofol (Diprivan): inject into large vein; prep site with lidocaine.
Adverse Effects:
Antipsychotics - Conventional
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Schizoaffective disorder
Dementia
Schizophrenia
Huntingtons chorea
Agranulocytosis
Sedation
Photosensitivity
Adverse Effects:
Anticholinergic effects
Ortho hypotension
Neuroendocrine effects
Seizures Parkinsonism
Sexual dysfunction
Dysrhythmias
Dystonia
Akathisia
Tardive dyskinesia
Neuroleptic malignant syndrome
Anticholinergics: CNS depressants: Additive effects
Interactions:
Levodopa: Counteracts antipsychotics by stimulating dopamine receptors
Consider depot preparations
Protect liquid prep from
Education:
Early EPS symptoms with anticholinergics, -blockers, benzodiazepines
Antipsychotics - Atypical
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Action results from blocking serotonin and dopamine receptors (block other
receptors, too) -- Pr developing EPS or tardive dyskinesia
Severe schizophrenia
Therapeutic Uses:
Psychosis induced by levodopa therapy
Agranulocytosis (WBC<3000/cc, Neu<1500/cc)
Adverse Effects:
Weight gain
New onset diabetes
Seizures
Myocarditis (dyspnea, RR, lethargy, chest pain, palpitations)
Contraindications/Precautions:
Interactions:
Immunosuppressive medications: Avoid
Education:
N203
ATI (Unit 5)
Nervous System -
RBC=4.7-6.1 x 1012/L
PO2=75-100 mm Hg
Hgb=14-18 g/dL
PCO2=34-45 mm Hg
Hct=42-52%
PT=11-12.5 s
PTT=60-70 s
Na =135-145 mEq/L
Cl =100-108 mEq/L
Ca =9-10.5 mEq/L
K+=3.5-5 mEq/L
PO43-=3-4.5 mg/dL
Mg2+=1.3-2.1 mEq/L
Prot=6-8 g/dL
BUN=8-25 mg/dL
Alb=3.5-5 g/dL
Neu=55-70%
(2,500-8,000)
2+
Osm=275-295 mOsm/kg
Lym=20-40%
(1,000-4,000)
Creatinine=0.6-1.5 mg/dL
Mon=2-8%
(100-700)
Eos=1-4%
(50-500)
Cue
N203
ATI (Unit 5)
Nervous System -
Response
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Selective Serotonin
Reuptake Inhibitors (SSRIs)
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Sexual
dysfunction
Weight
gain
Rash
Adverse Effects:
Withdrawal syndrome
Sleepiness, faintness
Hyponatremia
Serotonin syndrome 2-72 hrs (confusion, anxiety, agitation, hallucinations)
Pregnancy (C)
Contraindications/Precautions:
CI: MAOIs
MAOIs risk of serotonin syndrome
Interactions:
Warfarin warfarin levels
TCA & Lithium levels of these
NSAIDs & anticoagulants fluoxetine suppresses platelets bleeding risk
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Contraindications/Precautions:
CI: SSRIs, pheochromocytoma, cardiovascular disease & renal insufficiency
Indirect sympathomimetic release NE causing hypertensive
Interactions:
crisis
TCA hypertensive crisis
SSRIs serotonin syndrome
Meperidine
Antihypertensives additive hypotensive effect
hyperpyrexia
Tyramine-rich foods hypertensive crisis (aged cheese, salami, avocados,
bananas, protein, & red wine)
Vasopressors (phenylethylamine, caffeine) hypertension
Therapeutic Uses:
Atypical Antidepressants
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Depression
Seizures
Pregnancy B
risk of toxicity
Mood Stabilizers
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Interactions:
Diuretics Na+ lithium excretion toxicity
NSAIDs renal absorption lithium toxicity (aspirin OK)
Anticholinergics abdominal discomfort from urinary retention & polyuria
Maintain adequate sodium intake and 8-12 glasses of H2O
Education:
Plasma lithium levels must be monitored (> 1.5 mEq/L is toxic)
Sedative-Hypnotics -Benzodiazepines
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Interactions:
CNS depressants additive effects
Education:
Therapeutic Uses:
Sedative-Hypnotics
Non-Benzodiazepine
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Therapeutic Uses:
Management of insomnia
Adverse Effects:
Daytime sleepiness and lightheadedness
Contraindications/Precautions:
Interactions:
CNS depressants additive effects
Food absorption when taken with food
Education:
Anxiolytic Non-Barbiturate
N203
ATI (Unit 5)
Nervous System -
Expected Action:
CNS effects
NO SEDATION
Adverse Effects:
Contraindications/Precautions:
Erythromycin, ketoconazole, and grapefruit juice effects of buspirone
Does NOT potentiate CNS depressants
Interactions:
Education:
Take with meals to prevent gastric irritation
Therapeutic Uses:
CNS Stimulants
N203
ATI (Unit 5)
Nervous System -
Expected
Action:
Contraindications/Precautions:
Caution: hyperthyroidism, heart disease, glaucoma, Hx of drug abuse, MAOIs
Interactions:
Caffeine CNS stimulant effects
MAOIs hypertensive crisis
Phenytoin, warfarin, phenobarbital Inhibited metabolism of these
levels
OTC cold & decongestants CNS stimulant effects
Education:
Therapeutic Uses:
Drugs of Abuse
Alcohol
N203
ATI (Unit 5)
Nervous System -
Withdrawal Symptoms
Support Meds:
Maintenance Meds:
Drugs of Abuse
Opioids
N203
ATI (Unit 5)
Nervous System -
Withdrawal Symptoms
Detox Meds:
Methadone substitution
Maintenance Meds:
Drugs of Abuse
Nicotine
N203
ATI (Unit 5)
Nervous System -
Withdrawal Symptoms
Support Meds:
Education
Chew gum over 30 minutes; avoid eating and drinking within 15 minutes of
gum
Gum not recommended for use longer than 6 months
Avoid use of all nicotine products while pregnant or breastfeeding.
N203
ATI (Unit 5)
Nervous System -
Expected Action:
Diabetes insipidus
Cardiac arrest
Contraindications/Precautions:
(X) Pregnancy